
Meet the expert panel exploring the challenges involved in GLP-1 analysis in this LCGC International Peer Exchange®.
In this application note, infliximab and trastuzumab were separated on a BioResolve SCX mAb Column, and their charge variant fractions were collected using a Waters Fraction Manager-Analytical (WFM-A).






